Table 4.
Reported biological activities of the natural compounds present in the ethanolic extract of Schinus terebenthifolius.
| Compound | Activity | References |
|---|---|---|
| Gallic acid | Antitumoral | (Varela-Rodríguez et al., 2020) |
| Antidiabetic and cardioprotective | (Uddin et al., 2020) | |
| Antimicrobial, anticancer and against gastrointestinal, cardiovascular, neuropsychological and metabolic diseases | (Kahkeshani et al., 2018) | |
| Antioxidant, anticancer, anti-inflammatory, antimicrobial, antimelanogenic, and anti-allergic and antiviral (showed inhibition of replication of human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 and 2 (HSV)) | (Badhani et al., 2015) | |
| Antimicrobial and antiviral (evaluated against HSV-1 viruses as a representative of DNA viruses and PI-3 as a representative of RNA viruses, with significant activity) | (Özcelik et al., 2010) | |
| Antiviral (fraction of Rubus coreanus seed extract and its gallic acid derivative were evaluated against strains of influenza A and B. Both showed potential and broad antiviral activity. | (Lee et al., 2016) | |
| Catechin | Antimicrobial and antiviral (showed inhibition against Herpes simplex virus type 1 (HSV-1) | (Musarra-Pizzo et al., 2019) |
| Anti-oxidant, antitumor, antibacterial, antifungal, antidiabetic, anti-inflammatory, antiproliferative and antitumor | (Cosarcã et al., 2019) | |
| Antioxidant, UV protective, anti-allergenic, anti-inflammatory, anti-microbial, anti-viral and anti-cancer | (Bae et al., 2020) | |
| Antiviral (showed inhibition against pandemic influenza A (H1N1) | (You et al., 2018) | |
| Epicatechin | Antiviral (showed inhibitory effect against Mayaro (MAYV) virus and other alphavirus viruses | (Ferreira et al., 2018) |
| Antinociceptive and anti-inflammatory | (Dias et al., 2018) | |
| Antibacterial | (Ezhil and Lakshmi, 2017) | |
| Antidiabetic | (Ibrahim et al., 2018) | |
| Anti-infective | (Song, 2017) | |
| Anti-oxidant, antimicrobial, anti-inflammatory, antitumor, antidiabetic, anticancer and cardioprotective | (Prakash et al., 2019) | |
| Antioxidant and anticollagenase (showed a high inhibitory power against the collagenase enzyme, responsible for the degradation of matrix collagen and the photo-aging process. | (Geeta et al., 2019) | |
| UV protection | (Prasanth et al., 2020) | |
| Coumaric acid | Anti-oxidant and antihyperlipidemic | (Shen et al., 2019) |
| Anti-inflammatory | (Sabitha et al., 2019) | |
| Cytotoxic and leishmanicidal | (Arruda et al., 2020) | |
| Antioxidant, antimelanogenic, antimicrobial | (Boo, 2019) | |
| Antioxidant, antimicrobial, antimutagenesis, anticancer and antiviral (inhibition against the hepatitis C virus) | (Pei et al., 2015) | |
| Antioxidant and anti-aging (showed inhibitory activity against the enzymes elastase, collagenase and hyaluronidase) | (Widowati et al., 2020) | |
| Resveratrol | Antioxidant, antifungal and anti-staphylococcal | (Dwibedi and Saxena, 2019) |
| Anti-inflammatory, antioxidant, anti hyperlipidemic, immunomodulator, anticarcinogenic, cardioprotective, vasorelaxant, and neuroprotective | (Shaito et al., 2020) | |
| Antiviral (showed MERS-CoV infection and prolonged cellular survival after virus infection, in addition, decreased the expression of the nucleocapsid (N) protein essential for the duplication of the virus. | (Lin et al., 2017) | |
| Antiviral (exerted antiviral effects against Zika virus (ZIKV) replication in a dose-dependent manner) | (Mohd et al., 2019) | |
| UV protective (inhibited UVB-induced apoptosis by promoting HSP27 expression) | (Zhou et al., 2018) |